Xu Q - Search Results

1

Relaxin reverses cardiac and renal fibrosis in spontaneously hypertensive rats.

Lekgabe ED, Kiriazis H, Zhao C, Xu Q, Moore XL, Su Y, Bathgate RA, Du XJ, Samuel CS. Lekgabe ED, et al. Among authors: xu q. Hypertension. 2005 Aug;46(2):412-8. doi: 10.1161/01.HYP.0000171930.00697.2f. Epub 2005 Jun 20. Hypertension. 2005. PMID: 15967869

2

Endogenous relaxin does not affect chronic pressure overload-induced cardiac hypertrophy and fibrosis.

Xu Q, Lekgabe ED, Gao XM, Ming Z, Tregear GW, Dart AM, Bathgate RA, Samuel CS, Du XJ. Xu Q, et al. Endocrinology. 2008 Feb;149(2):476-82. doi: 10.1210/en.2007-1220. Epub 2007 Nov 8. Endocrinology. 2008. PMID: 17991721

3

Reversal of cardiac fibrosis and related dysfunction by relaxin.

Du XJ, Xu Q, Lekgabe E, Gao XM, Kiriazis H, Moore XL, Dart AM, Tregear GW, Bathgate RA, Samuel CS. Du XJ, et al. Among authors: xu q. Ann N Y Acad Sci. 2009 Apr;1160:278-84. doi: 10.1111/j.1749-6632.2008.03780.x. Ann N Y Acad Sci. 2009. PMID: 19416203

4

Relaxin therapy reverses large artery remodeling and improves arterial compliance in senescent spontaneously hypertensive rats.

Xu Q, Chakravorty A, Bathgate RA, Dart AM, Du XJ. Xu Q, et al. Hypertension. 2010 May;55(5):1260-6. doi: 10.1161/HYPERTENSIONAHA.109.149369. Epub 2010 Mar 29. Hypertension. 2010. PMID: 20351343

5

Relaxin remodels fibrotic healing following myocardial infarction.

Samuel CS, Cendrawan S, Gao XM, Ming Z, Zhao C, Kiriazis H, Xu Q, Tregear GW, Bathgate RA, Du XJ. Samuel CS, et al. Among authors: xu q. Lab Invest. 2011 May;91(5):675-90. doi: 10.1038/labinvest.2010.198. Epub 2011 Jan 10. Lab Invest. 2011. PMID: 21221074 Free article.

6

H3 relaxin demonstrates antifibrotic properties via the RXFP1 receptor.

Hossain MA, Man BC, Zhao C, Xu Q, Du XJ, Wade JD, Samuel CS. Hossain MA, et al. Among authors: xu q. Biochemistry. 2011 Mar 1;50(8):1368-75. doi: 10.1021/bi1013968. Epub 2011 Jan 31. Biochemistry. 2011. PMID: 21229994

7

Mouse model of post-infarct ventricular rupture: time course, strain- and gender-dependency, tensile strength, and histopathology.

Gao XM, Xu Q, Kiriazis H, Dart AM, Du XJ. Gao XM, et al. Among authors: xu q. Cardiovasc Res. 2005 Feb 1;65(2):469-77. doi: 10.1016/j.cardiores.2004.10.014. Cardiovasc Res. 2005. PMID: 15639486

8

Infarct size and post-infarct inflammation determine the risk of cardiac rupture in mice.

Gao XM, Ming Z, Su Y, Fang L, Kiriazis H, Xu Q, Dart AM, Du XJ. Gao XM, et al. Among authors: xu q. Int J Cardiol. 2010 Aug 6;143(1):20-8. doi: 10.1016/j.ijcard.2009.01.019. Epub 2009 Feb 4. Int J Cardiol. 2010. PMID: 19195725

9

Arginase II knockout mouse displays a hypertensive phenotype despite a decreased vasoconstrictory profile.

Huynh NN, Andrews KL, Head GA, Khong SM, Mayorov DN, Murphy AJ, Lambert G, Kiriazis H, Xu Q, Du XJ, Chin-Dusting JP. Huynh NN, et al. Among authors: xu q. Hypertension. 2009 Aug;54(2):294-301. doi: 10.1161/HYPERTENSIONAHA.108.121731. Epub 2009 Jun 22. Hypertension. 2009. PMID: 19546381

10

Chronic activation of the low affinity site of β1-adrenoceptors stimulates haemodynamics but exacerbates pressure-overload cardiac remodelling.

Kiriazis H, Tugiono N, Xu Q, Gao XM, Jennings NL, Ming Z, Su Y, Klenowski P, Summers RJ, Kaumann A, Molenaar P, Du XJ. Kiriazis H, et al. Among authors: xu q. Br J Pharmacol. 2013 Sep;170(2):352-65. doi: 10.1111/bph.12272. Br J Pharmacol. 2013. PMID: 23750586 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

20,319 results

Search Page

Filters